According to the report, the discussion reflects growing concern within federal agencies about inconsistencies in how cannabis-related products are being regulated under current law. While marijuana remains federally controlled, enforcement priorities have shifted in recent years due to expanding state legalization and the proliferation of hemp-derived intoxicants following changes made under the 2018 Farm Bill framework. That legal structure opened the door for a wide range of novel cannabinoids, which regulators have struggled to classify consistently.
The meeting also comes at a time when broader cannabis policy questions are still unresolved at the federal level, including ongoing debate over rescheduling, banking access for cannabis businesses, and how to distinguish between legal hemp products and intoxicating compounds derived from hemp. Industry stakeholders are expected to raise concerns about regulatory uncertainty, compliance burdens, and uneven enforcement across states.
Overall, the planned session underscores that cannabis policy remains in flux at the federal level, with enforcement agencies continuing to reassess how to manage a market that has rapidly outpaced existing regulatory frameworks.
If you liked this post, say thanks by sharing it
